Loading...
Insight Molecular Diagnostics Community
NasdaqCM:IMDX Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
Community Investing Ideas
Rising Global Organ Transplants Will Drive Diagnostic Testing Expansion
Key Takeaways Expanding clinical adoption and demographic trends are set to boost recurring revenue and gross margins through increased testing volume and broader market penetration. Strategic focus on high-margin digital PCR kits and new partnerships diversifies income sources, enhances profitability, and lessens dependence on external financing.Read more
1users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$7
17.7% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue
40.97% p.a.
Profit Margin
16.03%
Future PE
121.65x
Price in 2028
US$8.33
